Insider Trading activities of Hologic Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hologic Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hologic Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Hologic Inc since 2005. The reporting company's ticker symbol is HOLX. The reporting company's CIK number is 859737.
The total value of stock buying since 2005 is $10,989,754.
The total value of stock sales since 2005 is $552,024,348.
The total value of stock option exercises since 2005 is $123,197,115.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Hologic Inc insiders (HOLX) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-08-20 Brady David J (SVP, Human Resources) Option Ex 32,000 14.50 464,000
2013-08-15 Muir Glenn P (Executive VP and CFO) Sale 28,000 22.49 629,720
2013-08-15 Muir Glenn P (Executive VP and CFO) Option Ex 28,000 3.56 99,764
2013-08-08 Casey Mark J (SVP, CAO & General Counsel) Sale 14,804 22.57 334,126
2013-08-08 Levy Lawrence M (Director) Sale 5,000 22.50 112,500
2013-08-06 Hastie Rohan (Group VP & GM, Diagnostics) Option Ex 1,272 22.58 28,721
2013-07-19 Lavallee Robert H (SVP, Chief Accounting Officer) Sale 11,254 20.89 235,096
2013-07-15 Muir Glenn P (Executive VP and CFO) Sale 28,000 19.78 553,840
2013-07-15 Muir Glenn P (Executive VP and CFO) Option Ex 28,000 3.56 99,764
2013-07-01 Cascella Robert (CEO and President) Sale 20,000 19.55 391,000
2013-07-01 Cascella Robert (CEO and President) Option Ex 20,000 3.56 71,260
2013-06-17 Muir Glenn P (Executive VP and CFO) Sale 28,000 21.42 599,760
2013-06-17 Muir Glenn P (Executive VP and CFO) Option Ex 28,000 3.56 99,764
2013-06-03 Cascella Robert (CEO and President) Sale 20,000 20.71 414,200
2013-06-03 Cascella Robert (CEO and President) Option Ex 20,000 3.56 71,260
2013-03-11 Lavance David R Jr (Director) Sale 17,771 22.12 393,094
2013-03-11 Lavance David R Jr (Director) Option Ex 12,774 18.82 240,406
2013-02-27 Soltani Peter (SVP & GM, Women's Health) Sale 88,729 22.04 1,955,853
2013-02-27 Soltani Peter (SVP & GM, Women's Health) Option Ex 88,729 14.44 1,280,891
2013-02-25 Levy Lawrence M (Director) Sale 5,000 22.00 110,000
2013-02-21 Soltani Peter (SVP & GM, Women's Health) Sale 4,826 21.29 102,745
2013-02-14 Brady David J (SVP, Human Resources) Sale 20,000 22.20 444,000
2013-02-14 Brady David J (SVP, Human Resources) Option Ex 20,000 13.87 277,300
2013-02-01 Cascella Robert (CEO and President) Sale 21,984 23.50 516,514
2013-02-01 Cascella Robert (CEO and President) Option Ex 21,984 1.92 42,209
2013-01-09 Casey Mark J (SVP, CAO & General Counsel) Sale 129,526 22.04 2,854,753
2013-01-09 Casey Mark J (SVP, CAO & General Counsel) Option Ex 124,602 15.83 1,972,075
2013-01-02 Cascella Robert (CEO and President) Sale 21,985 20.39 448,384
2013-01-02 Cascella Robert (CEO and President) Option Ex 21,985 1.92 42,211
2012-12-14 Lavallee Robert H (SVP, Chief Accounting Officer) Sale 14,281 19.88 283,906
2012-12-13 Wilson Wayne (Director) Sale 22,878 19.76 452,069
2012-12-13 Wilson Wayne (Director) Option Ex 24,604 18.32 450,745
2012-12-03 Cascella Robert (CEO and President) Sale 21,656 18.85 408,215
2012-12-03 Cascella Robert (CEO and President) Option Ex 21,656 1.92 41,579
2012-11-15 Stein Jay A (Chief Technical Officer) Sale 55,980 19.52 1,093,009
2012-11-15 Stein Jay A (Chief Technical Officer) Option Ex 40,000 3.56 142,520
2012-11-01 Cascella Robert (CEO and President) Sale 21,875 21.01 459,593
2012-11-01 Cascella Robert (CEO and President) Option Ex 21,875 1.92 42,000
2012-09-14 Brady David J (SVP, Human Resources) Sale 15,000 20.66 309,900
2012-09-14 Brady David J (SVP, Human Resources) Option Ex 15,000 15.75 236,250
2012-09-12 Muir Glenn P (Executive VP and CFO) Sale 42,900 19.84 851,350
2012-09-12 Muir Glenn P (Executive VP and CFO) Option Ex 68,750 2.38 163,281
2012-09-07 Harding David (SVP, International) Sale 7,800 20.15 157,170
2012-09-07 Harding David (SVP, International) Option Ex 7,800 18.32 142,896
2012-09-06 Harding David (SVP, International) Sale 63,220 20.17 1,275,147
2012-09-06 Harding David (SVP, International) Option Ex 46,020 18.32 843,086
2012-09-05 Muir Glenn P (Executive VP and CFO) Sale 68,750 19.96 1,372,250
2012-09-05 Muir Glenn P (Executive VP and CFO) Option Ex 68,750 2.38 163,281
2012-08-22 Muir Glenn P (Executive VP and CFO) Sale 68,750 19.66 1,351,625
2012-08-22 Muir Glenn P (Executive VP and CFO) Option Ex 68,750 2.38 163,281
2012-08-08 Muir Glenn P (Executive VP and CFO) Sale 68,750 19.69 1,353,687
2012-08-08 Muir Glenn P (Executive VP and CFO) Option Ex 68,750 2.38 163,281
2012-08-07 Soltani Peter (SVP, Breast Health) Sale 418 19.99 8,355
2012-08-06 Crawford Sally (Director) Sale 24,604 19.70 484,698
2012-08-06 Crawford Sally (Director) Option Ex 24,604 18.32 450,745
2012-08-06 Soltani Peter (SVP, Breast Health) Sale 8,017 19.69 157,854
2012-06-08 Casey Mark J (SVP, General Counsel) Sale 3,985 16.79 66,908
2012-05-08 Cascella Robert (CEO and President) Option Ex 25,000 1.92 48,000
2012-05-08 Muir Glenn P (Executive VP and CFO) Option Ex 25,000 2.38 59,375
2012-05-02 Cascella Robert (CEO and President) Sale 12,500 18.53 231,625
2012-05-02 Cascella Robert (CEO and President) Option Ex 12,500 1.92 24,000
2012-03-08 Lavance David R Jr (Director) Sale 4,649 20.75 96,466
2012-03-07 Williamson Steve S (SVP, GYN Surgical) Sale 3,649 20.31 74,111
2012-03-02 Cascella Robert (CEO and President) Sale 12,500 20.87 260,875
2012-03-02 Cascella Robert (CEO and President) Option Ex 12,500 1.92 24,000
2012-02-16 Lavallee Robert H (SVP, Chief Accounting Officer) Sale 9,381 21.00 197,001
2012-02-10 Levy Lawrence M (Director) Sale 5,000 20.70 103,524
2012-02-10 Crawford Sally (Director) Sale 30,000 20.52 615,600
2012-02-03 Brady David J (SVP, Human Resources) Sale 27,421 21.11 578,775
2012-02-03 Brady David J (SVP, Human Resources) Option Ex 19,961 15.85 316,282
2012-02-03 Ullian Elaine (Director) Sale 4,649 20.71 96,280
2012-01-12 Crawford Sally (Director) Option Ex 24,604 18.46 454,312
2012-01-10 Casey Mark J (SVP, General Counsel) Sale 10,416 18.75 195,300
2012-01-10 Casey Mark J (SVP, General Counsel) Option Ex 10,416 18.46 192,331
2012-01-06 Harding David (SVP, International) Sale 42,266 18.53 783,188
2012-01-06 Harding David (SVP, International) Option Ex 42,266 18.46 780,441
2011-11-10 Muir Glenn P (Executive VP and CFO) Sale 100,000 17.09 1,709,100
2011-11-10 Muir Glenn P (Executive VP and CFO) Option Ex 100,000 2.56 256,500
2011-11-07 Muir Glenn P (Executive VP and CFO) Option Ex 50,000 2.56 128,250
2011-10-07 Muir Glenn P (Executive VP and CFO) Option Ex 50,000 2.56 128,250
2011-05-23 Stein Jay A (Chief Technical Officer) Sale 400,000 20.76 8,304,000
2011-05-09 Harding David (SVP, International) Sale 159,308 22.41 3,569,614
2011-05-09 Harding David (SVP, International) Option Ex 159,308 16.46 2,621,891
2011-03-11 Lavallee Robert H (SVP, Chief Accounting Officer) Sale 7,219 21.48 155,028
2011-03-11 Lavallee Robert H (SVP, Chief Accounting Officer) Option Ex 5,000 3.56 17,815
2011-03-08 Casey Mark J (SVP, General Counsel) Sale 6,610 21.27 140,594
2011-03-08 Cumming John W (Chairman) Sale 70,449 21.37 1,505,495
2011-03-07 Lavance David R Jr (Director) Sale 16,071 21.00 337,491
2011-03-07 Lavance David R Jr (Director) Option Ex 16,071 14.50 233,029
2011-03-07 Cumming John W (Chairman) Sale 12,100 21.26 257,246
2011-03-04 Crawford Sally (Director) Sale 6,694 20.92 140,038
2011-03-03 Cumming John W (Chairman) Sale 50,000 21.25 1,062,500
2011-02-23 Soltani Peter (SVP, Breast Health) Sale 16,528 19.84 327,915
2011-02-18 Lavance David R Jr (Director) Sale 6,034 20.63 124,481
2011-02-16 Williamson Steve S (SVP, GYN Surgical) Sale 1,707 20.26 34,583
2011-02-15 Williamson Steve S (SVP, GYN Surgical) Sale 16,800 19.95 335,244
2011-02-15 Williamson Steve S (SVP, GYN Surgical) Option Ex 16,800 14.30 240,240
2011-02-11 Williamson Steve S (SVP, GYN Surgical) Sale 3,880 19.58 75,982
2011-02-11 Crawford Sally (Director) Sale 13,000 19.89 258,635
2011-02-09 Williamson Steve S (SVP, GYN Surgical) Sale 5,766 19.49 112,379
2011-02-09 Williamson Steve S (SVP, GYN Surgical) Option Ex 5,766 14.24 82,136
2011-02-09 Casey Mark J (SVP, General Counsel) Sale 7,020 19.50 136,890
2011-02-09 Casey Mark J (SVP, General Counsel) Option Ex 7,020 15.81 110,986
2011-02-08 Wilson Wayne (Director) Sale 9,949 19.60 195,000
2011-02-08 Wilson Wayne (Director) Option Ex 12,302 15.81 194,494
2011-02-03 Leaming Nancy (Director) Option Ex 20,000 3.40 68,000
2011-01-18 Crawford Sally (Director) Option Ex 24,604 15.81 388,989
2011-01-03 Crawford Sally (Director) Option Ex 46,000 13.49 620,770
2010-11-24 Williamson Steve S (SVP, GYN Surgical) Sale 2,762 16.76 46,299
2010-11-24 Casey Mark J (SVP, General Counsel) Sale 3,098 16.80 52,046
2010-03-12 Doran Howard Jr (SVP, Diagnostics Products) Sale 7,688 18.50 142,228
2010-03-12 Doran Howard Jr (SVP, Diagnostics Products) Option Ex 7,688 15.81 121,547
2010-02-26 Casey Mark J (SVP, General Counsel) Sale 2,219 17.10 37,949
2010-02-04 Levy Lawrence M (Director) Sale 6,694 16.36 109,513
2010-02-04 Lavance David R Jr (Director) Sale 24,575 16.33 401,309
2010-02-04 Lavance David R Jr (Director) Option Ex 17,881 13.07 233,704
2010-02-03 Williamson Steve S (SVP, GYN Surgical) Sale 1,384 16.50 22,836
2010-02-03 Williamson Steve S (SVP, GYN Surgical) Option Ex 1,384 12.59 17,417
2009-11-02 Muir Glenn P (Executive VP and CFO) Sale 70,000 14.80 1,036,280
2009-11-02 Muir Glenn P (Executive VP and CFO) Option Ex 70,000 5.09 356,090
2009-10-30 Muir Glenn P (Executive VP and CFO) Option Ex 70,000 5.09 356,090
2009-09-21 Muir Glenn P (Executive VP and CFO) Option Ex 50,000 4.75 237,500
2009-08-31 Stein Jay A (Chief Technical Officer) Option Ex 10,000 2.38 23,750
2009-08-26 Lavallee Robert H (SVP, Chief Accounting Officer) Sale 17,500 16.19 283,325
2009-08-26 Lavallee Robert H (SVP, Chief Accounting Officer) Option Ex 17,500 5.09 89,022
2009-08-20 Brady David J (SVP, Human Resources) Sale 25,000 15.68 392,100
2009-08-20 Brady David J (SVP, Human Resources) Option Ex 25,000 3.56 89,075
2009-08-19 Cumming John W (Chairman & CEO) Sale 265,000 15.67 4,152,020
2009-08-19 Cumming John W (Chairman & CEO) Option Ex 265,000 5.09 1,348,055
2009-08-14 Cascella Robert (President & COO) Sale 140,000 14.83 2,075,780
2009-08-14 Cascella Robert (President & COO) Option Ex 140,000 4.75 665,000
2009-08-06 Brady David J (SVP, Human Resources) Sale 25,000 14.30 357,500
2009-08-06 Brady David J (SVP, Human Resources) Option Ex 25,000 3.56 89,075
2009-05-19 Doran Howard Jr (SVP, Diagnostics Products) Buy 3,500 11.97 41,891
2009-05-05 Soltani Peter (SVP, Breast Health) Buy 4,000 12.67 50,680
2008-08-07 Cascella Robert (President & COO) Buy 24,600 20.20 496,920
2008-08-07 Muir Glenn P (Executive VP & CFO) Buy 50,000 19.80 990,000
2008-08-07 Cumming John W (Chairman & CEO) Buy 100,000 20.03 2,003,098
2008-08-04 Doran Howard Jr (President, Diagnostics) Buy 100 18.26 1,826
2008-06-13 Mcdaniel C William (Director) Buy 20,000 23.40 468,000
2008-05-01 Muir Glenn P (Executive VP & CFO) Option Ex 16,832 1.45 24,322
2008-02-06 Muir Glenn P (Executive VP and CFO) Sale 5,000 64.06 320,300
2008-02-06 Muir Glenn P (Executive VP and CFO) Option Ex 5,000 9.50 47,500
2008-01-31 Wilson Wayne (Director) Buy 5 62.32 311
2008-01-24 Muir Glenn P (Executive VP and CFO) Option Ex 24,000 3.00 72,000
2008-01-07 Lerner Arthur G (Director) Sale 42,000 70.00 2,940,000
2008-01-07 Lerner Arthur G (Director) Option Ex 42,000 34.56 1,451,436
2008-01-04 Crawford Sally (Director) Sale 6,960 71.77 499,519
2008-01-04 Crawford Sally (Director) Option Ex 6,960 26.14 181,899
2008-01-04 Wilson Wayne (Director) Sale 5,000 71.77 358,850
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HOLX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hologic Inc (symbol HOLX, CIK number 859737) see the Securities and Exchange Commission (SEC) website.